Phospholipids and phospholipase A1 as antigens during the course of experimental Trypanosoma cruzi infection
Memórias do Instituto Oswaldo Cruz · 2025
DOI: 10.1590/0074-02760240281 ↗Kurz gefasst
Fachartikel in der Zeitschrift Memórias do Instituto Oswaldo Cruz, 2025. Verfasst von Emanuel Bott und 4 weiteren Autor:innen. Beteiligte Einrichtung: Universidad de Buenos Aires, Facultad de Medicina, Departamento de Microbiología, Parasitología e Inmunología, Buenos Aires, Argentina. Hauptthemen laut MEDLINE: Trypanosoma cruzi, Chagas Disease, Phospholipases A1, Antibodies, Protozoan. Die Arbeit nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: UBA.
Abstract (Originalsprache)
BACKGROUND Trypanosoma cruzi, causative agent of Chagas disease (CD), remains a public health problem in Latin America and is emerging in non-endemic areas. Phospholipids (PL) are essential components of biomembranes and their enzymatic modification by phospholipases yields bioactive lipids that modulate immune responses. Anti-PL antibodies have been associated with autoimmune diseases and inflammation, potentially influencing CD pathology by recognising PL and PL-binding proteins. T. cruzi Phospholipase A1 (TcPLA1) hydrolyses membrane PL and participates in parasite-host cell interactions. OBJECTIVES This study evaluated IgM and IgG antibody responses against phosphatidylcholine, phosphatidylethanolamine, and their derived lysophospholipids (LPL), as well as recombinant TcPLA1, during experimental T. cruzi infection with two strains: RA (high virulence) and K98 (low virulence). It also aimed to predict the recognition capacity of TcPLA1 by CD patients using in silico analysis. METHODS Antibody responses were analysed by enzyme-linked immunosorbent assay (ELISA) using different PL and recombinant TcPLA1 as antigens. Lytic activity assays were performed to evaluate the functional impact of anti-PL antibodies. The CHAGASTOPE resource was used to predict TcPLA1 antigenicity. FINDINGS This study identified IgM and IgG antibodies against PL, LPL and TcPLA1 during experimental T. cruzi infection. Different amino acid sequences of TcPLA1 showed stronger antigenic recognition by CD patient’s sera. MAIN CONCLUSIONS The presence of these antibodies suggests their involvement in the pathogenesis of CD and their potential as markers for disease monitoring and prognosis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Universidad de Buenos Aires, Facultad de Medicina, Departamento de Microbiología, Parasitología e Inmunología, Buenos Aires, Argentina.
- Consejo Nacional de Investigaciones Científicas y Técnicas-CONICET, Universidad de Buenos Aires, Instituto de Investigaciones en Microbiología y Parasitología Médica, Buenos Aires, Argentina.
- Universidad Nacional de Luján, Departamento de Ciencias Básicas, Buenos Aires, Argentina.
Förderung
- UBA
Zitieren
APA
Bott, E., López, S. A., Gimenez, G., Solana, M. E., & Belaunzarán, M. L. (2025). Phospholipids and phospholipase A1 as antigens during the course of experimental Trypanosoma cruzi infection. Memórias do Instituto Oswaldo Cruz. https://doi.org/10.1590/0074-02760240281
Vancouver
Bott E, López SA, Gimenez G, Solana ME, Belaunzarán ML. Phospholipids and phospholipase A1 as antigens during the course of experimental Trypanosoma cruzi infection. Memórias do Instituto Oswaldo Cruz. 2025. doi:10.1590/0074-02760240281
BibTeX
@article{Bott2025,
author = {Bott, Emanuel and López, Sebastián Andrés and Gimenez, Guadalupe and Solana, María Elisa and Belaunzarán, María Laura},
title = {Phospholipids and phospholipase A1 as antigens during the course of experimental Trypanosoma cruzi infection},
journal = {Memórias do Instituto Oswaldo Cruz},
year = {2025},
doi = {10.1590/0074-02760240281}
}
EUVIMED